
You can purchase shares of iShares Neuroscience and Healthcare ETF (ARCA:IBRN) through any online brokerage.
There are no as such competitors for iShares Neuroscience and Healthcare ETF.
There is no analysis for iShares Neuroscience and Healthcare ETF to provide a consensus price target.
The stock price for iShares Neuroscience and Healthcare ETF (ARCA: IBRN) is $31.91 last updated October 7, 2026 at 9:29 AM EDT.
There are no upcoming dividends for iShares Neuroscience and Healthcare ETF.
iShares Neuroscience and Healthcare ETF does not have any upcoming earnings scheduled.
There is no upcoming split for iShares Neuroscience and Healthcare ETF.
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | Aug 24, 2022 |
| Managers | Peter Sietsema Jennifer Hsui Steven White Matt Waldron |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| XENE | Xenon Pharmaceuticals ... | 4.46% |
| SRRK | Scholar Rock Holding C... | 4.92% |
| IE | Alkermes Plc. Ordinary... | 4.23% |
| ARWR | Arrowhead Pharmaceutic... | 4.46% |
| BIIB | Biogen Inc. | 4.37% |
| PRAX | Praxis Precision Medic... | 5.18% |
| ACAD | Acadia Pharmaceuticals | 4.94% |
| DNTH | Dianthus Therapeutics ... | 5.19% |
| AS | Argenx Se Sponsored Ad... | 4.35% |
| NBIX | Neurocrine Biosciences... | 3.75% |
Benzinga Rankings give you vital metrics on any stock – anytime.